Domain binding and isotype dictate the activity of anti-human OX40 antibodies

BACKGROUND: Previous data suggests that anti-OX40 mAb can elicit anti-tumor effects in mice through deletion of Tregs. However, OX40 also has powerful costimulatory effects on T cells which could evoke therapeutic responses. Human trials with anti-OX40 antibodies have shown that these entities are w...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Jordana, Hussain, Khiyam, Smith, Hannah L, Sanders, Theodore, Cox, Kerry L, Semmrich, Monika, Mårtensson, Linda, Kim, Jinny, Inzhelevskaya, Tatyana, Penfold, Chris A, Tutt, Alison L, Mockridge, C Ian, Chan, HT Claude, English, Vikki, French, Ruth F, Teige, Ingrid, Al-Shamkhani, Aymen, Glennie, Martin J, Frendeus, Bjorn L, Willoughby, Jane E, Cragg, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754644/
https://www.ncbi.nlm.nih.gov/pubmed/33428585
http://dx.doi.org/10.1136/jitc-2020-001557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754644/
https://www.ncbi.nlm.nih.gov/pubmed/33428585
http://dx.doi.org/10.1136/jitc-2020-001557

Ejemplares similares